Literature DB >> 17259079

Albumin inhibits cytotoxic activity of lysophosphatidylcholine by direct binding.

Yu-Lee Kim1, Young-Jin Im, Nam-Chul Ha, Dong-Soon Im.   

Abstract

Fetal bovine serum (FBS) was found to protect Jurkat T cells from LPC-induced cytotoxicity. Twenty micromolar LPC-induced cytotoxicity of 80-90% of the cells in media without FBS for 3 h, whereas 50-70% in media with 0.5% FBS. However, LPC-induced cytotoxicity was not observed in the presence of 5% FBS in media. The cytotoxicity was specific for LPC among lysophospholipids tested and significantly observed with palmitoyl (C16:0) LPC, stearoyl (C18:0) LPC, and oleoyl (C18:1) LPC among 11 synthetic LPCs. Furthermore, the cytoprotective effect of FBS was observed only when it was added before the treatment, but not after the treatment of LPC, and premixing of FBS and LPC before addition to the cells ameliorated LPC-induced cytotoxicity. Finally, albumin, a major constituent of FBS, prevented completely LPC-induced cytotoxicity even at as low as 3 microM concentration. We also found that five molecules of LPC could sequentially bind to one BSA using isothermal titration calorimetry. The above results suggest that the cytotoxic activity of LPC could be attenuated by albumin in blood. Finally, it should be cautioned that, when experiments are conducted with LPC dissolved in assay buffers containing albumin, the albumin in the buffer could influence the results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17259079     DOI: 10.1016/j.prostaglandins.2006.10.006

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  22 in total

1.  Antibody purification via affinity membrane chromatography method utilizing nucleotide binding site targeting with a small molecule.

Authors:  Nur Mustafaoglu; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Analyst       Date:  2016-11-28       Impact factor: 4.616

2.  Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production.

Authors:  Monika Riederer; Pauli J Ojala; Andelko Hrzenjak; Wolfgang F Graier; Roland Malli; Michaela Tritscher; Martin Hermansson; Bernhard Watzer; Horst Schweer; Gernot Desoye; Akos Heinemann; Sasa Frank
Journal:  J Lipid Res       Date:  2010-07-07       Impact factor: 5.922

3.  Micromolar changes in lysophosphatidylcholine concentration cause minor effects on mitochondrial permeability but major alterations in function.

Authors:  Norris I Hollie; James G Cash; M Abdul Matlib; Matthew Wortman; Joshua E Basford; William Abplanalp; David Y Hui
Journal:  Biochim Biophys Acta       Date:  2013-12-05

4.  Lysophosphatidylcholine induces adenosine release from macrophages via TRPM7-mediated mitochondrial activation.

Authors:  Ahmed M Youssef; Dong-Keun Song
Journal:  Purinergic Signal       Date:  2022-07-02       Impact factor: 3.950

5.  Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length.

Authors:  Patricia Cmielewski; Don S Anson; David W Parsons
Journal:  Respir Res       Date:  2010-06-23

Review 6.  G2A and LPC: regulatory functions in immunity.

Authors:  Janusz H Kabarowski
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-04-19       Impact factor: 3.072

7.  Lysophosphatidylcholine exhibits selective cytotoxicity, accompanied by ROS formation, in RAW 264.7 macrophages.

Authors:  Cheon Ho Park; Mee Ree Kim; Jong-Min Han; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2009-02-28       Impact factor: 1.880

8.  Lysolipid containing liposomes for transendothelial drug delivery.

Authors:  Tilen Koklic; Janez Trancar
Journal:  BMC Res Notes       Date:  2012-04-10

9.  Endothelial lipase (EL) and EL-generated lysophosphatidylcholines promote IL-8 expression in endothelial cells.

Authors:  Monika Riederer; Margarete Lechleitner; Andelko Hrzenjak; Harald Koefeler; Gernot Desoye; Akos Heinemann; Saša Frank
Journal:  Atherosclerosis       Date:  2010-11-13       Impact factor: 5.162

10.  Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties.

Authors:  Timothy J Cunningham; Lihua Yao; Angel Lucena
Journal:  J Inflamm (Lond)       Date:  2008-10-22       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.